Meiotically arrested oocytes contain diffused chromosomes surrounded by an intact nuclear structure known as the germinal vesicle (GV). Upon reinitiation of meiosis, the chromosomes recondense and the GV breaks down (GVBD). The first meiotic division proceeds through metaphase I and is accomplished by the formation of the first polar body. Completion of meiosis I is immediately followed by entry into the second meiotic division, which is arrested again at metaphase II. At this stage of oogenesis, the oocyte matures into a haploid egg and is ready for fertilization. Resumption of meiosis is therefore also referred to as oocyte maturation (reviewed by Dekel 1986Dekel , 1995.
Meiotically arrested oocytes contain diffused chromosomes surrounded by an intact nuclear structure known as the germinal vesicle (GV). Upon reinitiation of meiosis, the chromosomes recondense and the GV breaks down (GVBD). The first meiotic division proceeds through metaphase I and is accomplished by the formation of the first polar body. Completion of meiosis I is immediately followed by entry into the second meiotic division, which is arrested again at metaphase II. At this stage of oogenesis, the oocyte matures into a haploid egg and is ready for fertilization. Resumption of meiosis is therefore also referred to as oocyte maturation (reviewed by Dekel 1986 Dekel , 1995 .
The presence of a maturation promoting factor (MPF) associated with the G2 to M phase transition was reported initially in frog oocytes (Masui and Markert, 1971) . Further experiments demonstrating an increased protein phosphorylation in cells microinjected with a crude MPF preparation suggested that this factor contained a protein kinase activity. Later purification of MPF allowed the identification of its 34 and 45 kDa subunits. Use of different fractions of purified MPF have further demonstrated that the 45 kDa subunit apparently lacks kinase activity. Nevertheless, this subunit as well as exogenous substrates such as histone H1 are phosphorylated by fractions that contain the 34 kDa protein component (reviewed by Maller, 1994) .
The strong preference of MPF kinase for histone H1 as a substrate has been used for the demonstration and semiquantitation of MPF activity in mammalian oocytes. Determination of H1 kinase activity in cytoplasmic extracts of fully grown pig (Naito and Toyoda, 1991; Fulka et al., 1992) , mouse (Rime and Ozon, 1990; Choi et al., 1991) and rabbit (Jelinkova et al., 1994) oocytes throughout meiosis revealed dynamic changes that corresponded to the different stages of the cell cycle. In all these studies, meiotically arrested GV oocytes displayed a relatively low activity of histone H1 kinase. This enzyme activity increased significantly at metaphase I and was followed by an abrupt reduction in oocytes emitting the first polar body. The activity of histone H1 kinase increased again at metaphase II and remained high until fertilization or parthenogenetic egg activation. An identical pattern of oscillations of MPF activity was demonstrated in a study in which the ability of microinjected cytoplasmic extracts of donor maturing mouse oocytes to induce maturation in recipient, meiotically arrested starfish oocytes was evaluated (Hashimoto and Kishimoto, 1988) . Taken together, these studies suggest that the biological activity of MPF and its enzymatic action as a protein kinase are indistinguishable. They further suggest that promotion of oocyte maturation could involve the phosphorylation of histone H1. Moreno and Nurse (1990) suggested that a phosphorylated histone H1 alters the nucleosome packing and contributes to chromosome condensation. The specific phosphoproteins that possibly serve as substrates for MPF kinase upon transition from G2 to M phase will be discussed later in this review.
Regulation of MPF activity
The significant progress in our understanding of the mechanisms underlying the regulation of MPF activity was made possible by incorporation of molecular information generated by genetic studies in yeasts into the biochemical data accumulated using frog oocytes and eggs. This convergence led to the discovery that the 34 kDa component of MPF is a homologue of the protein product of the cdc2 gene of fission yeast. Further studies revealed that this protein, referred to as p34 cdc2 , is highly conserved among eukaryotes and exhibits a serine/threonine kinase activity. The second component of MPF was later identified as a B-type cyclin homologous to another yeast cell cycle control gene product known as cdc13 (reviewed by Maller, 1994) .
Association with cyclin is regarded as essential for p34 cdc2 kinase activity. The regulation of MPF kinase activity by the amount of cyclin available does not appear to involve phosphorylation or dephosphorylation events and will therefore not be discussed further in this review. Another obligatory step for activation of the cyclin-p34 cdc2 complex is the removal of the phosphate from tyrosine 15 of p34 cdc2 . Results obtained from frog oocytes revealed that this step is subjected to the control of specific protein tyrosine phosphatase and kinase, homologous to the protein products of the cdc25 and wee1 genes of fission yeast, respectively (reviewed by Maller, 1994) . These enzymes, or other specific phosphatases and kinases that possibly regulate the tyrosine phosphorylated state of p34 cdc2 have not yet been identified in mammalian oocytes. Nevertheless, evidence that resumption of meiosis in rodent oocytes involves tyrosine dephosphorylation of p34 cdc2 is provided by experiments using vanadate, an inhibitor of protein tyrosine phosphatases. This agent, which prevents tyrosine dephosphorylation of p34 cdc2 in mouse (Choi et al., 1992) and rat (Goren and Dekel 1994; Fig. 1 ) oocytes, has also been shown to act as an effective inhibitor of oocyte maturation (Dekel and Goren 1992; Goren and Dekel 1994; Fig. 2) .
The phosphorylated form of p34 cdc2 present in G2-arrested rodent oocytes disappears 2 h after the onset of meiosis, with no further change until metaphase II (Choi et al., 1991; Goren and Dekel, 1994) . However, histone H1 kinase activity, which is high during metaphase I and II, decreases at polar body extrusion. Taken together, these results suggest that, in maturing mammalian oocytes, dephosphorylation of p34 cdc2 triggers its activation upon entry into the first metaphase. However, the cell-cycle-dependent oscillatory pattern of MPF activity observed upon exit from the first and entry into the second meiotic metaphase is not associated with another round of phosphorylation/dephosphorylation of p34 cdc2 . The mechanism responsible for the disassociation between tyrosine dephosphorylation of p34 cdc2 and its kinase activity is not yet understood.
Another major issue that is poorly understood relates to the mechanism that accounts for the arrest of the meiotic cell cycle in G2 by cAMP. Inhibition of MPF activation by cAMP was suggested by experiments demonstrating that meiotically arrested Xenopus oocytes fused with maturing, but not with dibutyryl cAMP-arrested, mouse oocytes are induced to resume meiosis (Sorensen et al., 1985) . However, fusion of metaphase II mouse oocytes rapidly induces GVBD in dibutyryl cAMParrested homologous oocytes, suggesting that once cytoplasmic MPF has been activated, its ability to induce the transition of nuclei to metaphase is no longer sensitive to cAMP (Clarke and Masui, 1985) . It has been suggested that it is not the expression of p34 cdc2 , but rather post-translational modification of this protein, that is regulated by cAMP in the meiotic prophase. Specifically, mouse (Choi et al., 1991) and rat (Goren and Dekel, 1994) oocytes arrested at G2 phase by isobutyl methylxanthine (IBMX), a phosphodiesterase inhibitor that maintains a relatively high intra-oocyte concentration of cAMP, clearly express the phosphorylated, inactive form of p34 cdc2 . Dephosphorylation of p34 cdc2 can be demonstrated in such oocytes after removal of IBMX (Fig. 3) . These findings offer evidence for a possible negative regulation of p34 cdc2 dephosphorylation by cAMP.
The possible correlation between cAMP and p34 cdc2 kinase activation has been further examined by determinations of intra-oocyte concentrations of cAMP in oocytes incubated with vanadate (Goren and Dekel, 1994) . These experiments revealed that, in spite of the fact that these oocytes are maintained in meiotic arrest, they contain concentrations of cAMP that are comparable with those in GVBD oocytes (Fig. 4) . As mentioned earlier, in this experimental model vanadate prevents the dephosphorylation of p34 cdc2 kinase, inhibiting its activation. These findings demonstrate that the maturation-associated decrease in intracellular concentrations of cAMP is essential, but not sufficient, for reinitiation of meiosis. They further suggest that p34 cdc2 dephosphorylation is distal to the decrease in cAMP concentration. This idea is further supported by kinetic studies that show that the irreversible commitment of rat oocytes to resume meiosis (Dekel and Beers, 1980) , resulting from the decrease in cAMP (Aberdam et al., 1987) , occurs just before the dephosphorylation of p34 cdc2 (Goren and Dekel, 1994) . Bornslaeger et al. (1986) reported that an inhibitor of PKA can induce maturation in IBMX-arrested mouse oocytes. This suggests that an activated PKA mediates the negative action of cAMP on resumption of meiosis. Further experimental evidence related to the biochemical events that link the cAMP-activated PKA to other downstream regulatory elements of the cell cycle in the mammalian oocyte is needed. One such link may be provided by either a protein tyrosine phosphatase or a protein tyrosine kinase that is directly or indirectly regulated by PKA (Fig. 5) .
Several phosphoproteins could serve as substrates for the active p34 cdc2 kinase in the meiotic metaphases. Among these, RNA polymerase II (Cisek and Corden, 1989) and vimentin (Chou et al., 1990) , which are phosphorylated by p34 cdc2 kinase, could be included. In addition, highly purified p34 cdc2 kinase phosphorylates B1 and B2 lamins, solubilizes lamin B from nuclei and causes nuclear lamina disassembly (Peter et al., 1990) . All these reports suggest a possible role for p34 cdc2 kinase in metaphase on transcription or translation regulation, microfilament rearrangement, reorganization of the intermediate filament network, and nuclear disassembly, respectively.
Mitogen-activated protein kinase
The specific mode of regulation of the meiotic cell cycle in the oocyte that allows the fall in the activity of MPF at the end of meiosis I, in the absence of p34 cdc2 dephosphorylation, is not known. The mechanism that prevents the events that are normally associated with MPF inactivation, such as chromosome decondensation, nuclear formation and interphasic reorganization of the microtubule network, has not been elucidated. These biochemical functions may be executed by a kinase other than p34 cdc2 , which stays active between the two meiotic metaphases.
Members of the mitogen-activated protein (MAP) family are serine/threonine protein kinases that are activated upon their concomitant phosphorylation on specific tyrosine and threonine residues. Once activated, these kinases can phosphorylate many of the same sites as MPF. Indeed, the presence of two isoforms (42 kDa and 44 kDa) of MAP kinase has been shown in mouse (Sobajima et al., 1993; Verlhac et al., 1993) and rat (Goren et al., 1994) oocytes, and MAP kinase activity that rises as the oocytes enter meiosis I and remains high throughout oocyte maturation has been demonstrated (Sobajima et al., 1993; Verlhac et al., 1993; N. Dekel, unpublished) . These findings suggest that MAP kinase may phosphorylate some of the substrates modified by the active MPF, preventing the oocyte from entering interphase between metaphase I and II.
A role for MAP kinase, which is not limited to the transition phase between the two meiotic metaphases, is suggested by kinetic analysis of microtubule organization in maturing mouse oocytes (Verlhac et al., 1994) . This study reveals that the assembly of the first meiotic spindle correlates better temporally with MAP kinase, than with MPF, activation. It also shows that MAP kinase activation is delayed after histone H1 kinase activation, possibly localizing MAP kinase downstream to MPF. However, a study by Sobajima et al. (1993) used oocytes of the same species, but showed reverse temporal relationships between activation of these two kinases, making it difficult to establish their relative loci along the signal transduction pathway that finally leads to resumption of meiosis in mammalian oocytes. The possibility that in mammals, as in amphibians, a common signal that induces oocyte maturation activates these two kinases in parallel cannot at present be excluded.
Mos kinase
The c-mos proto-oncogene is expressed exclusively in male and female germ cells (Mutter and Wolgemuth, 1987) , suggesting a specific function for its protein product, Mos, in the meiotic cell cycle. Mos is a serine/threonine kinase that has been detected in mouse oocytes throughout meiosis. Its presence has been demonstrated in oocytes arrested at the first meiotic prophase, during GVBD, at metaphase and anaphase I, as well as in oocytes arrested at metaphase II (Paules et al., 1989) . In Xenopus, Mos has been identified as a key regulator of meiosis. It is required for the activation of MPF, for GVBD, for the formation of the first polar body and for reactivation of MPF at metaphase II (reviewed by Yew et al., 1993) . Mos in frogs is also an active component of the cytosolic factor (CSF), which holds unfertilized eggs arrested at meiotic metaphase II (Sagata et al., 1989) .
Microinjection of c-mos antisense oligonucleotides into G2-arrested mouse oocytes, however, does not prevent them from entering into M phase of the cell cycle. These oocytes successfully undergo GVBD, but fail to emit the first polar body (Paules et al., 1989) . Furthermore, the loss of c-mos function in these maturing oocytes interferes with the progression to meiosis II and leads to chromosome condensation, nuclear membrane formation and oocyte cleavage (O'Keefe et al., 1989) . These findings suggest that, in mammals, MPF activation that is associated with the G2 to M phase transition is independent of Mos kinase. However, the unique characteristics of the transition phase between the two meiotic metaphases in oocytes, such as karyokinesis in the absence of cytokinesis, dephosphorylated but kinase inactive p34 cdc2 and high MAP-kinase activity, may be subjected to regulation by the mos protooncogene protein product.
However, recent experiments seem to indicate that Mos kinase does not have a role in preventing mammalian oocytes from entering intrameiotic interphase between metaphase I and II. These experiments used targeted disruption of the c-mos gene in embryonic stem cells to generate a mos-deficient mouse model (Colledge et al., 1994; Hashimoto et al., 1994) . Analysis of the oocytes of these mutant mice revealed that their capacity to reinitiate meiotic maturation and their potential to progress through metaphase I to metaphase II were not affected. However, their ability to arrest at metaphase II was severely impaired, resulting in spontaneous parthenogenetic activation. These results suggest that of all its activities in Xenopus, Mos kinase in mouse is only necessary for metaphase arrest of oocytes at meiosis II before fertilization. Mos is a potent activator of the MAP kinase pathway. Furthermore, phosphorylation of MAP kinase in frog oocytes appears to be mediated through Mos kinase (Posada et al., 1993) . The activity of MAP kinase is raised soon after reinitiation of meiosis and this is sustained until exit from metaphase II (Sobajima et al., 1993) . MAP kinase is involved in reorganization of microtubules that leads to the spindle formation at metaphase I and also contributes to the stabilization of the spindle at metaphase II (Verlhac et al., 1993) . Taken together, these findings seem to conflict with the demonstrated capacity of Mos-deficient mouse oocytes to progress through metaphase I and II of meiosis. One likely explanation for this apparent contradiction is that mammalian oocytes express a redundant activity, such as the Ras/Raf pathway, that can compensate in the mutant mice for the depleted activity of Mos kinase. The ability of Ras to induce meiotic maturation and high MPF activity independently of endogenous Mos has been shown in Xenopus oocytes (Daar et al., 1991) .
Acquisition of meiotic competence
The physiological trigger for resumption of meiosis is provided by the preovulatory surge of LH. However, when oocytes are removed from the ovarian follicles and placed in culture, meiotic maturation occurs in the absence of gonadotrophins (reviewed by Dekel, 1986) . The ability to resume meiosis in vitro spontaneously is apparently not shared by all of the ovarian oocytes, even though they seem to represent one homogeneous cell population arrested at the first prophase of meiosis. Results of experiments performed in oocytes of hamsters (Iwamatsu and Yanagimachi, 1975) , mice (Sorensen and Wasserman, 1976) , rats (Bar-Ami and Tsafriri, 1981) , rabbits (Jelinkova et al., 1994) , cows and pigs (Motlik et al., 1986) indicate that this ability is acquired progressively during oocyte growth. Accordingly, oocytes that are incompetent and competent to resume meiosis are referred to as growing and fully grown, respectively. Goren et al. (1994) showed that growing rat oocytes fail to resume meiosis not only spontaneously, but also in response to hormonal stimuli.
In spite of the accumulating information about the biochemical and molecular control of the meiotic cell cycle, the nature of the restriction displayed by growing oocytes that prevents them from resuming meiosis remains largely unknown. In a pioneering study, Balakier (1978) succeeded in inducing growing mouse oocytes to resume meiosis by their fusion with maturing, fully grown oocytes. This raised the idea that meiotic competence can be acquired experimentally upon transfer of MPF, which is present in an active form in the cytoplasm of maturing, fully grown oocytes.
The hypothesis that growing oocytes, which are incompetent to resume meiosis, are deficient in their content of p34 cdc2 or cyclin B, the two subunits of MPF, has been analysed. Studies have revealed that growing, incompetent pig oocytes have already accumulated both p34 cdc2 and cyclin B in amounts similar to those found in competent, fully grown oocytes (Christmann et al., 1994) . Similarly, growing and fully grown rat oocytes also express comparable amounts of p34 cdc2 (Goren et al., 1994) . However, while the amounts of cyclin B in mice do not change significantly during the final stages of oocyte growth, increasing synthesis and accumulation of p34 cdc2 has been demonstrated in this species (Chesnel and Eppig, 1995a) , suggesting that insufficient amounts of the catalytic subunit of MPF is the limiting factor that renders growing mouse oocytes incompetent to resume meiosis.
In those growing oocytes that express sufficient amounts of p34 cdc2 and cyclin B, meiotic incompetence possibly represents a deficiency of regulatory elements responsible for MPF kinase activation. This assumption is apparently valid, at least for growing pig oocytes that fail to exhibit histone H1 kinase activity, in spite of the fact that they express maximal amounts of both MPF protein components (Christmann et al., 1994) . A role for upstream regulatory elements that control the acquisition of meiotic competence is also suggested by demonstrations that okadaic acid (OA), a specific inhibitor of protein phosphatases 1 and 2A, induces GVBD in growing rat, mouse and pig oocytes (Gavin et al., 1991; Christmann et al., 1994; N. Dekel, unpublished) . These reports suggest that the activity of MPF in incompetent oocytes is subjected to negative regulation by a type 2A phosphatase-sensitive protein.
Changes in microtubular morphology or activity may play an important role in the acquisition of meiotic competence. Incompetent oocytes contain nonphosphorylated microtubuleorganizing centres (MTOCs) with an interphasic network of microtubules radiating from them. By contrast, prophasearrested competent oocytes contain phosphorylated MTOCs, with much shorter microtubules that are perinuclear in location (Wickramasinghe et al., 1991; Wickramasinghe and Albertini, 1992) . These changes may be regulated in part by MAP kinase, which has been shown to phosphorylate a microtubuleassociated protein present in frog eggs (Shiina et al., 1992) . Furthermore, when added to cell-free extracts prepared from frog eggs, MAP kinase causes both the growth rate and the steady-state length of microtubules to decrease (Gotoh et al., 1991) .
The presence of the two isoforms of MAP kinase (the 42 kDa and 44 kDa) with no difference in their abundance has been demonstrated in growing and fully grown rat oocytes (Goren et al., 1994) . More recent reports confirm these findings for mouse oocytes (Chesnel and Eppig, 1995b; Harrouk and Clarke, 1995) . However, these reports present changes in the phosphorylation and autonomous activation of MAP kinase that take place as growing mouse oocytes acquire meiotic competence. Taken together, these studies suggest that it is not the absence, but rather the inability to stimulate the activity of the MAP kinase, that accounts for the interphasic pattern of microtubule organization associated with meiotic incompetence. Phosphorylation of MAP kinase in frog oocytes appears to be mediated through Mos (Posada et al., 1993) . The presence of Mos has been demonstrated successfully in fully grown oocytes, but has not been detected in growing mouse oocytes (Paules et al., 1989) . It is possible, therefore, that the failure of growing oocytes to stimulate MAP kinase may represent the absence of the c-mos protooncogene protein product.
A major difference between competent and incompetent oocytes, with regard to the role of cAMP in regulation of meiosis, has been shown. Reinitiation of meiosis in fully grown oocytes is associated with a fall in intra-oocyte cAMP concentration that appears to be an initial step in a cascade of events leading to oocyte maturation (reviewed by Dekel, 1988) . One such event is apparently activation of MPF. Goren et al. (1994) showed that a comparable decrease in intracellular cAMP concentration occurs in growing and fully grown oocytes upon their removal from the ovarian follicle (Fig. 6 ). These findings suggest that meiotic arrest in incompetent oocytes is independent of intra-oocyte cAMP concentrations. Microinjection of the heat-stable inhibitor of cAMP-dependent protein kinase (PKI), which induces GVBD in fully grown mouse oocytes, does not induce maturation in meiotically incompetent oocytes. Moreover, PKI microinjected into growing mouse oocytes does not allow the maturation-associated changes in protein phosphorylation observed in fully grown oocytes (Bornslaeger et al., 1988) . These findings suggest that MPF in incompetent mammalian oocytes is not negatively regulated by PKA-mediated cAMP action. Factor(s) responsible for meiotic incompetence in oocytes that have not reached their final size may be located at a point that is distal to cAMP, but before MPF, along the cascade of biochemical regulators of oocyte maturation. 
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